LF 16-0687

作者: Vicki Huffman

DOI: 10.1016/B978-008055232-3.63181-2

关键词:

摘要:

参考文章(9)
J. Schulz, Nikolaus Plesnila, J. Eriskat, M. Stoffel, D. Pruneau, A. Baethmann, LF16-0687 A Novel Non-Peptide Bradykinin B2 Receptor Antagonist Reduces Vasogenic Brain Edema from a Focal Lesion in Rats Acta Neurochirurgica. ,vol. 76, pp. 137- 139 ,(2000) , 10.1007/978-3-7091-6346-7_28
Janice Koepp, Cristofer André Caous, Giles Alexander Rae, Antonio Claudir Balan, Charles Julian Lindsey, Kinin and opioid receptors in the paratrigeminal nucleus modulate the somatosensory reflex to rat sciatic nerve stimulation. Peptides. ,vol. 26, pp. 1339- 1345 ,(2005) , 10.1016/J.PEPTIDES.2005.03.033
M. Petcu, J.P. Dias, B. Ongali, G. Thibault, W. Neugebauer, R. Couture, Role of kinin B1 and B2 receptors in a rat model of neuropathic pain. International Immunopharmacology. ,vol. 8, pp. 188- 196 ,(2008) , 10.1016/J.INTIMP.2007.09.009
Christopher G Sobey, Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy? British Journal of Pharmacology. ,vol. 139, pp. 1369- 1371 ,(2003) , 10.1038/SJ.BJP.0705415
Didier Pruneau, Jean Luc Paquet, Jean Michel Luccarini, Evelyne Defrêne, Chantal Fouchet, Rose-Marie Franck, Bruno Loillier, Claude Robert, Pierre Bélichard, Hervé Duclos, Béatrice Cremers, Pierre Dodey, Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. Immunopharmacology. ,vol. 43, pp. 187- 194 ,(1999) , 10.1016/S0162-3109(99)00128-9
S Zausinger, D.B Lumenta, D Pruneau, R Schmid-Elsaesser, N Plesnila, A Baethmann, Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia Brain Research. ,vol. 950, pp. 268- 278 ,(2002) , 10.1016/S0006-8993(02)03053-6
Steeve Houle, Jean-François Larrivée, Magdalena Bachvarova, Johanne Bouthillier, Dimcho R. Bachvarov, François Marceau, Antagonist-Induced Intracellular Sequestration of Rabbit Bradykinin B2 Receptor Hypertension. ,vol. 35, pp. 1319- 1325 ,(2000) , 10.1161/01.HYP.35.6.1319
Anthony Marmarou, Martine Guy, Laine Murphey, Francis Roy, Laure Layani, Jean-Philippe Combal, Claude Marquer, , A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury. Journal of Neurotrauma. ,vol. 22, pp. 1444- 1455 ,(2005) , 10.1089/NEU.2005.22.1444